hotspot -WSS

hotspot

author：fashion 2025-10-01 07:42:18 - browse：24

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Senate panel clears PBM, hopsital reforms

hotspot

WSS

Reports of telehealth's death have been greatly exaggerated

Investigation reveals sickle cell patients pressured into sterilizations

For longer

10 million people disenrolled from Medicaid over past six months

Making the case for fair compensation in clinical trials

Fentanyl is making it harder to start addiction treatment

knowledge

hotspot

knowledge

Sports medicine is finally prioritizing gender equality

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Trump demands the U.S. pay no more for drugs than other countries … again

Senate panel clears PBM, hopsital reforms

Anesthesiologist group: stop taking Ozempic before surgery

Liver decline slowed by off

Sports medicine is finally prioritizing gender equality

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Affirmative action in medical school literally saved lives

Biogen joins immunology wave with $1.15 billion acquisition of HI

explore

Abortion clinic in Cancun will cater to Americans

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Biogen joins immunology wave with $1.15 billion acquisition of HI

Fentanyl is making it harder to start addiction treatment

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

leisure time

Wikipedia

hotspot

explore